Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Inhibrx, Inc. (INBX) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Inhibrx, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1739614.
Total stock buying since 2020: $55,852,758.
Total stock sales since 2020: $27,693,398.
Total stock option exercises since 2020: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 300,000 | $10,290,000 | 0 | $0 |
| 2023 | 511,627 | $9,899,982 | 155,560 | $3,855,176 | 0 | $0 |
| 2022 | 1,333,333 | $39,999,990 | 306,900 | $8,484,488 | 0 | $0 |
| 2021 | 0 | $0 | 210,033 | $5,063,734 | 0 | $0 |
| 2020 | 311,684 | $5,952,786 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-05 | 0 | $0 | 300,000 | $10,290,000 | 0 | $0 |
| 2023-08 | 511,627 | $9,899,982 | 0 | $0 | 0 | $0 |
| 2023-03 | 0 | $0 | 40,000 | $978,160 | 0 | $0 |
| 2023-02 | 0 | $0 | 40,060 | $1,009,100 | 0 | $0 |
| 2023-01 | 0 | $0 | 75,500 | $1,867,916 | 0 | $0 |
| 2022-12 | 0 | $0 | 35,500 | $932,421 | 0 | $0 |
| 2022-11 | 0 | $0 | 155,500 | $5,064,740 | 0 | $0 |
| 2022-10 | 1,333,333 | $39,999,990 | 35,500 | $1,070,679 | 0 | $0 |
| 2022-08 | 0 | $0 | 40,000 | $719,832 | 0 | $0 |
| 2022-07 | 0 | $0 | 40,000 | $686,800 | 0 | $0 |
| 2022-04 | 0 | $0 | 400 | $10,016 | 0 | $0 |
| 2021-03 | 0 | $0 | 17,000 | $323,340 | 0 | $0 |
| 2021-02 | 0 | $0 | 193,033 | $4,740,394 | 0 | $0 |
| 2020-08 | 311,684 | $5,952,786 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-05-28 | Eckelman Brendan P. (Chief Scientific Officer) | Sale | 300,000 | 34.30 | 10,290,000 |
| 2023-08-28 | Shabet Rose Sharon | Buy | 511,627 | 19.35 | 9,899,982 |
| 2023-03-01 | Eckelman Living Trust Dated February 5, 2014 | Sale | 40,000 | 24.45 | 978,160 |
| 2023-02-28 | Lappe Family Trust | Sale | 60 | 25.02 | 1,501 |
| 2023-02-02 | Eckelman Living Trust Dated February 5, 2014 | Sale | 11,250 | 25.65 | 288,562 |
| 2023-02-01 | Eckelman Living Trust Dated February 5, 2014 | Sale | 28,750 | 25.01 | 719,037 |
| 2023-01-24 | Lappe Family Trust | Sale | 4,335 | 25.91 | 112,324 |
| 2023-01-23 | Lappe Family Trust | Sale | 21,665 | 25.36 | 549,359 |
| 2023-01-23 | Kayyem Jon Faiz | Sale | 9,500 | 25.26 | 239,998 |
| 2023-01-04 | Eckelman Living Trust Dated February 5, 2014 | Sale | 7,105 | 23.55 | 167,315 |
| 2023-01-03 | Eckelman Living Trust Dated February 5, 2014 | Sale | 32,895 | 24.29 | 798,920 |
| 2022-12-21 | Kayyem Jon Faiz | Sale | 9,500 | 27.24 | 258,761 |
| 2022-12-19 | Lappe Family Trust | Sale | 26,000 | 25.91 | 673,660 |
| 2022-11-21 | Kayyem Jon Faiz | Sale | 9,500 | 29.72 | 282,378 |
| 2022-11-17 | Lappe Family Trust | Sale | 26,000 | 28.78 | 748,202 |
| 2022-11-01 | Eckelman Living Trust Dated February 5, 2014 | Sale | 80,000 | 33.62 | 2,689,440 |
| 2022-10-21 | Kayyem Jon Faiz | Sale | 9,500 | 29.98 | 284,829 |
| 2022-10-17 | Lappe Family Trust | Sale | 26,000 | 30.23 | 785,850 |
| 2022-10-07 | Shabet Rose Sharon | Buy | 1,333,333 | 30.00 | 39,999,990 |
| 2022-08-03 | Eckelman Living Trust Dated February 5, 2014 | Sale | 15,500 | 18.46 | 286,207 |
| 2022-08-02 | Eckelman Living Trust Dated February 5, 2014 | Sale | 24,500 | 17.70 | 433,625 |
| 2022-07-07 | Eckelman Living Trust Dated February 5, 2014 | Sale | 40,000 | 17.17 | 686,800 |
| 2022-04-05 | Eckelman Living Trust Dated February 5, 2014 | Sale | 400 | 25.04 | 10,016 |
| 2021-03-24 | Eckelman Living Trust Dated February 5, 2014 | Sale | 17,000 | 19.02 | 323,340 |
| 2021-02-17 | Wagner Klaus W. (Chief Medical Officer) | Sale | 19,559 | 25.29 | 494,647 |
| 2021-02-16 | Eckelman Living Trust Dated February 5, 2014 | Sale | 17,000 | 25.90 | 440,300 |
| 2021-02-16 | Wagner Klaus W. (Chief Medical Officer) | Sale | 156,474 | 24.32 | 3,805,447 |
| 2020-08-26 | Shabet Rose Sharon | Buy | 180,219 | 18.91 | 3,408,481 |
| 2020-08-25 | Shabet Rose Sharon | Buy | 85,304 | 19.31 | 1,647,305 |
| 2020-08-24 | Shabet Rose Sharon | Buy | 46,161 | 19.43 | 897,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of INBX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Inhibrx, Inc. (symbol INBX, CIK number 1739614) see the Securities and Exchange Commission (SEC) website.